Salubris Biotherapeutics` JK06 ADC Trial Approved By European Regulator
05 Aug 2024 //
BUSINESSWIRE
Salubris Announces $35M Financing, Pipeline Update
22 Apr 2024 //
BUSINESSWIRE
Salubris Presents Positive Initial Data from Phase 1b/2 Clinical Trial of JK08
23 Oct 2023 //
BUSINESSWIRE
Salubris Presents Positive 6-Month Data from Phase 1b Clinical Trial of JK07
09 Oct 2023 //
BUSINESSWIRE